Injectable Drug Compatibility News
Winter 2025
In this update we added a new monograph for AZTREONAM AND AVIBACTAM. We included new stability information to the monograph for AZTREONAM AND AVIBACTAM. Compatibility information was added for these drugs: ACETAMINOPHEN, AMIODARONE HYDROCHLORIDE, BUMETANIDE, CEFAZOLIN SODIUM, CEFOTAXIME SODIUM, CLONIDINE HYDROCHLORIDE, FUROSEMIDE, HEPARIN SODIUM, HYALURONIDASE, HYDROCORTISONE SODIUM SUCCINATE, IBUPROFEN, INSULIN, REGULAR, ISOSORBIDE DINITRATE, LEVETIRACETAM, LEVOFLOXACIN, MAGNESIUM SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, PANTOPRAZOLE SODIUM, PHLOROGLUCINOL, PHYTONADIONE, POTASSIUM CHLORIDE, PYRIDOXINE HYDROCHLORIDE, REMIFENTANIL, THIAMINE HYDROCHLORIDE, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VANCOMYCIN HYDROCHLORIDE.
Fall 2025
New and updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.
Summer 2025
New & updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.
Spring 2025
New and updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.
Winter 2024